Jonathan West a micro-engineer and his colleagues at the University of Dortmund in Germany, has developed the new microarray chip which can test an estimated 30,000 chemicals their toxicological risk.
Called a Network Formation Assay (NFA), the chip lets researchers test compounds faster and more reliably. A normal drug test takes up to 10 hours because each compound is tested 30 times at 10 different doses. With this new chip, it will take just a few hours at most.
This approach involves patterning neuronal cells within a hexagonal array to standardize the distance between neighbouring cellular nodes, and thereby standardize the length of the neurite interconnections. This feature coupled with defined assay coordinates provides a streamlined display for rapid and sensitive analysis
The invention includes a new protocol for the detection of the neurite outgrowth, which requires neither fixation nor staining of cells.
For details contact
http://www.provendis.info/?id=496&L=3
http://www.rsc.org/publishing/journals/LC/article.asp?Type=AdvArticle&Page=0&GA=on
Filed under: microarray, Next Generation Drug Development, Next Generation of DNA and RNA Microarrays | Tagged: health sciences global business unit, Oracle health sciences global business unit | 1 Comment »